Pharmascience Delivers Life-saving Drugs with Real-time Document Management from OpenText

News provided by

Mar 28, 2019, 09:00 ET

OpenText Content Suite helps leading drug manufacturer manage complex and highly-regulated information management challenges

WATERLOO, Ontario, March 28, 2019 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX, TSX: OTEX), a global leader in Enterprise Information Management (EIM), today announced Pharmascience, a leading Canadian manufacturer of branded and generic pharmaceutical drugs, has deployed OpenText™ Content Suite to help manage its complex document management requirements.

Pharmascience produces over 2,000 products with sales in over 60 countries worldwide. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products. The company needed a scalable Enterprise Content Management (ECM) solution to manage and secure its document lifecycle and help respond to increasing regulatory demands. It needed a full range of document governance tools, including workflow management, version control and audit trails. OpenText Content Suite and OpenText Regulated Documents, helped to build a strategic, centralized repository for its most valuable business content.

"Operating with the highest standards for quality and regulatory compliance leaves us no room for error and we needed a partner that could operate at our level," said Denis Beauchemin, head of IT, Pharmascience. "Our work is high-stakes and highly-regulated, but we need to continue to move quickly and innovate. The solution from OpenText provides us with a single source of truth for our most critical set of documents and ensures our team can access the information they need in the lab, the shop floor, or the boardroom."

OpenText Professional Services worked with the expert team at Pharmascience to execute this ambitious digital transformation. The Pharmascience team brought their understanding of the regulatory and governance challenges to the table, while OpenText was able to deliver proactive solutions leveraging EIM expertise developed by working with 20 of the top 20 Life Sciences organizations worldwide.

Reinforcing its IT operational agility, Pharmascience is now working with OpenText Managed Services to handle ongoing Enterprise Information Management functions, ensuring in-house experts can focus on other critical business needs.

"We all rely on the pharmaceutical industry to supply the consistent and high-quality drugs our health systems require. With the world's top experts in Enterprise Information Management and experience working in highly-regulated environments like life sciences, the OpenText Managed Services team is helping Pharmascience improve its operational efficiency by driving digital transformation deeper," said James McGourlay, Executive Vice President, Customer Operations at OpenText. "Our customers are facing a rapidly changing business environment and they rely on OpenText to manage, monitor and optimize business systems and keep them one step ahead."

About OpenText
OpenText, The Information Company™, enables organizations to gain insight through market leading information management solutions, on premises or in the cloud. For more information about OpenText (NASDAQ: OTEX, TSX: OTEX) visit opentext.com.

Connect with us:
OpenText CEO Mark Barrenechea's blog
Twitter | LinkedIn

Certain statements in this press release may contain words considered forward-looking statements or information under applicable securities laws. These statements are based on OpenText's current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which the company operates. These statements are subject to important assumptions, risks and uncertainties that are difficult to predict, and the actual outcome may be materially different. OpenText's assumptions, although considered reasonable by the company at the date of this press release, may prove to be inaccurate and consequently its actual results could differ materially from the expectations set out herein. For additional information with respect to risks and other factors which could occur, see OpenText's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Unless otherwise required by applicable securities laws, OpenText disclaims any intention or obligations to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright © 2019 OpenText. All rights reserved. OpenText is a trademark or registered trademark of OpenText. The list of trademarks is not exhaustive of other trademarks. Registered trademarks, product names, company names, brands and service names mentioned herein are property of OpenText or other respective owners.

OTEX-G

SOURCE Open Text Corporation